These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 16077145

  • 1. Extraosseous calcification in patients with chronic renal failure--no escape?
    Braun J.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2054-9. PubMed ID: 16077145
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Secondary hyperparathyroidism in chronic kidney failure].
    Kalinin AP, Ivanov IA, Shcherbakova EO.
    Ter Arkh; 1986 Oct; 58(8):143-8. PubMed ID: 3532407
    [No Abstract] [Full Text] [Related]

  • 6. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
    Slatopolsky E, Rutherford WE, Martin K, Hruska K.
    Adv Exp Med Biol; 1977 Oct; 81():467-75. PubMed ID: 899937
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B, Belozeroff V.
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis].
    Kuhlencordt F, Augustin HJ, Kruse HP.
    Dtsch Med Wochenschr; 1970 Oct 16; 95(42):2122-5. PubMed ID: 4990903
    [No Abstract] [Full Text] [Related]

  • 15. New approaches to treatment of secondary hyperparathyroidism.
    Locatelli F, Limardo M, Pontoriero G.
    Curr Opin Investig Drugs; 2008 Apr 16; 9(4):363-70. PubMed ID: 18393103
    [Abstract] [Full Text] [Related]

  • 16. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ, Slatopolsky E.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 16; 3(2):134-44. PubMed ID: 17237840
    [Abstract] [Full Text] [Related]

  • 17. [Metastatic calcinosis or calciphylaxis--a case with a severe vascular calcification during intermittent hemodialysis].
    Pogglitsch H, Feldner H, Stöckl G, Holzer H.
    Wien Med Wochenschr; 1970 Jul 25; 120(30):532-4. PubMed ID: 5523384
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 25; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.